- Filed
- Feb 9, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Feb 9, 2024 | 59.66M sh |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | $1.04B |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | $777.29M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $6.41B |
| Total Liabilities | Q3 2024 · Mar 31, 2023 | $4.31B |
| Total Assets | Q3 2024 · Dec 31, 2023 | $7.45B |
| Total Assets | Q3 2024 · Mar 31, 2023 | $5.08B |
| Cash And Equivalents | Q3 2024 · Mar 31, 2023 | $581.42M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2022 | $664.1M |
| Shares Diluted | Q3 2024 · Dec 31, 2022 | 59.52B sh |
| Shares Diluted | Q3 2024 · Dec 31, 2022 | 59.53B sh |
| Capex | Q3 2024 · Dec 31, 2022 | $27.35M |
| Operating Cash Flow | Q3 2024 · Dec 31, 2022 | −$465.79M |
| Eps Diluted restated | Q3 2024 · Dec 31, 2022 | $1.05 |
| Eps Diluted restated | Q3 2024 · Dec 31, 2022 | $2.50 |
| Eps Basic restated | Q3 2024 · Dec 31, 2022 | $1.06 |
| Eps Basic restated | Q3 2024 · Dec 31, 2022 | $2.54 |
| Sga Expense | Q3 2024 · Dec 31, 2022 | $16.43M |
| Sga Expense | Q3 2024 · Dec 31, 2022 | $40.94M |
| Net Income | Q3 2024 · Dec 31, 2022 | $62.86M |
| Net Income | Q3 2024 · Dec 31, 2022 | $150.19M |
| Revenue restated | Q3 2024 · Dec 31, 2022 | $213.98M |
| Revenue restated | Q3 2024 · Dec 31, 2022 | $566.61M |